Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Gabapentin Dementia Lawsuit Gabapentin dementia lawsuits are being investigated against Pfizer and other drug manufacturers following studies linking the widely prescribed medication to an increased risk of dementia, Alzheimer's disease and mild cognitive impairment. Learn about the allegations, recent research, lawsuit updates and potential settlement compensation.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Chlorpyrifos Parkinsonโs Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinsonโs disease after direct, residential, occupational or Gulf War pesticide exposure.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Ozempic Stomach Risks Result in Debate Among Anesthesiologists Over Surgery GuidelinesSome anesthesiologists say patients should be taken off drugs three weeks before surgery to avoid risks caused by Ozempic stomach side effects September 13, 2023 Irvin Jackson Add Your CommentsAn increasing number of anesthesiologists are expressing concerns over recent guidelines on the use of new generation diabetes and weightloss drugs before surgery, suggesting that they do not go far enough to protect patients from Ozempic stomach risks, which could result in severe adverse health consequences.In late June, the American Society of Anesthesiologists (ASA) issued new Ozempic and Wegovy surgery guidelines that warned against using the drugs before elective surgery, due to the risk of vomiting and aspiration during anesthesia.Ozempic (semaglutide) was originally approved for the treatment of people with Type 2 diabetes. However, in recent monthsย Ozempic, along with a similar drug, Wegovy, has been increasingly prescribed for weight loss. While Wegovy is approved for weight loss use, Ozempic is not, and is prescribed โoff-labelโ as a diet medication by a growing number of doctors.Both drugs are part of a class of diabetic medications known as glucagon-like peptide-1 (GLP-1) receptor agonists, which also includes Trulicity, Byetta and others. However, side effects of Ozempic, Wegovy and other members of the class have been linked to serious stomach risks, including gastroparesis or stomach paralysis, which can result in severe and long-term gastrointestinal damage. As a result a growing number of Ozempic lawsuits have been filed in recent months, claiming that drug makers failed to adequately warn users and the medical community about the potential risks.Find Out If You Have a LawsuitWere you prescribed Ozempic, Wegovy or Mounjaro?Lawyers are pursuing Ozempic, Wegovy and Mounjaro lawsuits over serious side effects, including stomach paralysis, other gastrointestinal injuries and NAION, a rare optic nerve injury linked to sudden and potentially permanent vision loss.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONFind Out If You Have a LawsuitWere you prescribed Ozempic, Wegovy or Mounjaro?Lawyers are pursuing Ozempic, Wegovy and Mounjaro lawsuits over serious side effects, including stomach paralysis, other gastrointestinal injuries and NAION, a rare optic nerve injury linked to sudden and potentially permanent vision loss.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONThe ASA task force recommends that if patients take a drug like Ozempic or Wegovy on a daily basis, they should not take it the day of a surgery procedure. If they take the drug on a weekly basis, they should pause taking the medications a week before their surgery, according to the ASA, among other recommendations.According to the ASA guidance, the drugs work by delaying the emptying of the stomach, which leads to less hunger. However, that means that during surgery and anesthesia, the stomach may not be empty, which has been linked to patients vomiting and facing a suffocation risk.Ozempic Stomach Risk Guidance ConcernsSome anesthesiologists are now saying that those guidelines should be strengthened, and some have begun taking other measures to protect patients from Ozempic stomach risks, such as intubating them, even during only minor surgical procedures, according to a report published by MedPage Today, which indicated the debate has polarized the anesthesiologist community.In July, researchers with the Mayo Clinic, Massachusetts General Hospital, and Toronto General Hospital published a report in the Canadian Journal of Anesthesia, suggesting that surgeons should probably not limit their protection of patients to the ASA guidelines.Instead, they recommended patients be taken off any semaglutide-based drug for at least three weeks before surgery, to allow at least three half-lives to pass. This would mean about 88% of Ozempic or Wegovy are out of the patientโs system. If patients cannot be off the drugs that long before surgery, they called for doctors to consider rapid sequence induction intubation to limit the risk of patients emptying their stomach during the procedure.The researchers say that even if general anesthesia is not planned, health care providers should be made aware the patient is on Ozempic and the risks that their stomach contents might not be empty if general anesthesia is suddenly needed. They also called for surgeons to use gastric ultrasound to assess stomach contents and shared decision making with the patient, so that they are aware of the risks and benefits of any decisions.However, the researchers noted that there is very little definitive science linking semaglutide to surgical suffocation and vomiting risks, only compelling case reports and a few early studies, which makes any guidelines questionable.โThe above considerations are not clinical practice guidelines, as there is currently insufficient evidence to generate guidelines. They are opinion-based elements anesthesia providers should consider,โ the researchers noted. โThe considerations we give are a best attempt to balance the risk of a potentially life-threatening aspiration event against the risk to the patient of weight gain or temporarily poorer glycemic control.โOzempic and Wegovy Stomach Paralysis RisksGastroparesis, also known as delayed gastric emptying or stomach paralysis, weakens the normal muscle movement in the stomach. These stomach contractions are necessary to push food through the digestive tract.When gastroparesis occurs, the stomach is slow to empty, resulting in symptoms including nausea, vomiting undigested food, abdominal pain, abdominal bloating, severe dehydration, feeling full after only a few bites, undigested food hardening in the stomach, acid reflux, fluctuating blood sugar levels, lack of appetite, weight loss, malnutrition and decreased quality of life. However, some users are reporting these side effects persisted long after Wegovy or Ozempic are discontinued.In July, a CNN investigation outlined an alarming number of reports linking Ozempic and stomach paralysis, indicating that similar problems have been associated with other drugs in the same class in recent years.In 2017, researchers with the Mayo Clinic conducted aย studyย involving a similar diabetes medication known as Victoza, which found that the drug caused significantly slower digestion in users, taking about 70 minutes for half the food they ate to leave their stomachs, compared to four minutes for people who did not take the drug. However, the study found that peopleโs bodies tended to adjust over time.The first known Ozempic stomach paralysis lawsuit was filed in early August, alleging Novo Nordisk knew about the risks, but failed to provide patients and healthcare providers with adequate warning. It was the first of what could be hundreds or thousands of gastroparesis lawsuits filed in the coming months and years. Written by: Irvin JacksonSenior Legal Journalist & Contributing EditorIrvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Anesthesia, Diabetes, Diabetes Drugs, Gastroparesis, Novo Nordisk, Ozempic, Stomach Paralysis, Suffocation, Surgery, Wegovy, Weight Loss Find Out If You Qualify for Ozempic or Wegovy CompensationMore Ozempic, Wegovy and Mounjaro Lawsuit Stories FDA Requires New Vision Loss Warnings for Ozempic, Wegovy and Other GLP-1s Over NAION Risk November 9, 2026 Ozempic Blindness Lawsuit Alleges Novo Nordisk Concealed NAION Risks October 30, 2026 GLP-1 Vision Loss Lawsuit Alleges Ozempic Caused Man to Become Legally Blind October 13, 2026 0 Comments PhoneThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Lawsuit Claims Abbott Sales Reps Practiced Medicine Without a License While Adjusting Spinal Cord Stimulator (Posted: 2 days ago)An Abbott SCS lawsuit claims the company’s sales representatives performed unlicensed medical procedures, potentially delaying removal of a failed implant.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITConsolidated Lawsuit Over Boston Scientific Spinal Cord Stimulator Problems Filed in MDL (11/09/2026)Abbott Sales Reps Kept Trying to Reprogram Failed SCS Implant: Lawsuit (11/02/2026)Abbott Proclaim Elite Lawsuit Alleges Spinal Cord Stimulator Malfunction Worsened Chronic Pain (10/29/2026) Parkinsonโs Disease Lawsuit Claims Dow and Corteva Sold Dangerous Chlorpyrifos Despite Safer Alternatives (Posted: 3 days ago)A California man’s chlorpyrifos lawsuit blames years of exposure to the pesticide for the development of Parkinson’s disease that forced him out of his profession.MORE ABOUT: CHLORPYRIFOS PARKINSONโS DISEASE LAWSUITPesticide Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (11/13/2026)Chlorpyrifos Pesticide Exposure Detected in Infants, Raising New Neurotoxicity Concerns (11/03/2026)Chlorpyrifos Ban Takes Effect Across EU as Studies Link Pesticide Exposure to Parkinsonโs Disease (10/01/2026) Gabapentin Lawsuit Alleges Nerve Pain Drug Caused Severe Headaches, Memory Loss (Posted: 4 days ago)A Washington womanโs lawsuit claims she suffered persistent neurological problems after using gabapentin for fibromyalgia.MORE ABOUT: GABAPENTIN DEMENTIA LAWSUITNeurontin Dementia Lawsuit Alleges Gabapentin Caused Early-Onset Memory Loss (11/10/2026)Gabapentin Dementia Risks May Result in Lawsuits Against Drug Maker (09/17/2026)
FDA Requires New Vision Loss Warnings for Ozempic, Wegovy and Other GLP-1s Over NAION Risk November 9, 2026
Lawsuit Claims Abbott Sales Reps Practiced Medicine Without a License While Adjusting Spinal Cord Stimulator (Posted: 2 days ago)An Abbott SCS lawsuit claims the company’s sales representatives performed unlicensed medical procedures, potentially delaying removal of a failed implant.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITConsolidated Lawsuit Over Boston Scientific Spinal Cord Stimulator Problems Filed in MDL (11/09/2026)Abbott Sales Reps Kept Trying to Reprogram Failed SCS Implant: Lawsuit (11/02/2026)Abbott Proclaim Elite Lawsuit Alleges Spinal Cord Stimulator Malfunction Worsened Chronic Pain (10/29/2026)
Parkinsonโs Disease Lawsuit Claims Dow and Corteva Sold Dangerous Chlorpyrifos Despite Safer Alternatives (Posted: 3 days ago)A California man’s chlorpyrifos lawsuit blames years of exposure to the pesticide for the development of Parkinson’s disease that forced him out of his profession.MORE ABOUT: CHLORPYRIFOS PARKINSONโS DISEASE LAWSUITPesticide Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (11/13/2026)Chlorpyrifos Pesticide Exposure Detected in Infants, Raising New Neurotoxicity Concerns (11/03/2026)Chlorpyrifos Ban Takes Effect Across EU as Studies Link Pesticide Exposure to Parkinsonโs Disease (10/01/2026)
Gabapentin Lawsuit Alleges Nerve Pain Drug Caused Severe Headaches, Memory Loss (Posted: 4 days ago)A Washington womanโs lawsuit claims she suffered persistent neurological problems after using gabapentin for fibromyalgia.MORE ABOUT: GABAPENTIN DEMENTIA LAWSUITNeurontin Dementia Lawsuit Alleges Gabapentin Caused Early-Onset Memory Loss (11/10/2026)Gabapentin Dementia Risks May Result in Lawsuits Against Drug Maker (09/17/2026)